Generic Name and Formulations:
Dimenhydrinate 50mg; scored tabs.
McNeil Consumer Healthcare
Indications for DRAMAMINE:
Motion sickness prophylaxis.
50–100mg every 4–6 hours, starting ½–1 hour before travel; max 400mg/day.
<2 years: not recommended. 2–6 years: 12.5–25mg; max 75mg/day. 6–11 yrs: 25–50mg; max 150mg/day. Both: starting ½–1 hour before travel; may repeat every 6–8 hours.
Asthma or chronic respiratory disease. Glaucoma. Arrhythmias. GI or urinary obstruction. Phenylketonuria (chewable tabs). Pregnancy (Cat.B). Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants. May potentiate ototoxicity of antibiotics (esp. aminoglycosides).
Drowsiness, sedation, anticholinergic effects, paradoxical excitement in children.
Tabs—12, 36, 100
Endocrinology Advisor Articles
- Behavioral Weight Loss Interventions May Prevent Obesity
- Executive Function Predicts T1D Management Into Emerging Adulthood
- Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D
- Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Bioethics Concerns Should Be a Key Element in mHealth Technology Development
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- High Prevalence of Obstructive Sleep Apnea Syndrome May Favor Screening in Diabetes
- Update on the T2D-Dementia Link: Interview With Experts
- Dozens of Medical Groups Join Forces to Improve Diagnoses